Inherited lipid metabolism disorder
MONDO:0002525An inherited metabolic disorder caused by an enzyme deficiency, resulting in an inability to oxidize fatty acids for energy production.
Also known as: disorder of lipid metabolism, dyslipidaemia, dyslipidemia, lipid metabolism disorder, fatty acid metabolism disorder
644 clinical trials for this condition and its sub-types, 201 tagged with Inherited lipid metabolism disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Inherited lipid metabolism disorder
-
Lysosomal lipid storage disorder 2 trials · 192 incl. sub-types
7 sub-types
- Sphingolipidosis 6 trials · 166 incl. sub-types Sub-types →
- Cerebral lipidosis with dementia 0 trials · 38 incl. sub-types Sub-types →
- Neuronal ceroid lipofuscinosis 6 trials · 23 incl. sub-types Sub-types →
- Xanthomatosis 2 trials · 8 incl. sub-types Sub-types →
- Lysosomal acid lipase deficiency 4 trials · 6 incl. sub-types Sub-types →
- Neutral lipid storage disease 1 trial · 2 incl. sub-types Sub-types →
- Triglyceride storage disease 0 trials Sub-types →
-
Familial hyperlipidemia 8 trials · 130 incl. sub-types
10 sub-types
- Familial hypercholesterolemia 58 trials · 94 incl. sub-types Sub-types →
- Hyperlipidemia, familial combined, LPL related 22 trials
- Familial lipoprotein lipase deficiency 6 trials
- Hyperlipoproteinemia type 3 4 trials
- Hyperlipoproteinemia type V 2 trials
- Cholesterol-ester transfer protein deficiency 0 trials
- Familial apolipoprotein C-II deficiency 0 trials
- Hyperlipidemia due to hepatic triglyceride lipase deficiency 0 trials
- Hyperlipidemia, combined, 2 0 trials
- Hyperlipoproteinemia, type 1D 0 trials
-
Syndromic dyslipidemia 0 trials · 73 incl. sub-types
29 sub-types
- CHILD syndrome 37 trials
- Smith-Lemli-Opitz syndrome 6 trials
- Cerebrotendinous xanthomatosis 6 trials
- Familial lipoprotein lipase deficiency 6 trials
- Lysosomal acid lipase deficiency 4 trials · 6 incl. sub-types Sub-types →
- Barth syndrome 5 trials
- Mevalonate kinase deficiency 3 trials · 4 incl. sub-types Sub-types →
- GM1 gangliosidosis type 1 3 trials
- Sjogren-Larsson syndrome 3 trials
- Nephrotic syndrome 14 3 trials
- Apparent mineralocorticoid excess 1 trial
- Neuronal ceroid lipofuscinosis 8 northern epilepsy variant 1 trial
- Peroxisome biogenesis disorder due to PEX5 defect in the PEX7-binding domain 0 trials · 1 incl. sub-types Sub-types →
- Rhizomelic chondrodysplasia punctata type 1 1 trial
- CHIME syndrome 0 trials
- Krabbe disease due to saposin A deficiency 0 trials
- PHARC syndrome 0 trials
- Autosomal recessive complex spastic paraplegia due to kennedy pathway dysfunction 0 trials
- Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome 0 trials
- Familial apolipoprotein C-II deficiency 0 trials
- Fatty acid hydroxylase-associated neurodegeneration 0 trials
- Hereditary spastic paraplegia 39 0 trials Sub-types →
- Hyperlipoproteinemia, type 1D 0 trials
- Hyperphosphatasia-intellectual disability syndrome 0 trials Sub-types →
- Intellectual disability, autosomal recessive 53 0 trials
- Lipoprotein glomerulopathy 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 2 0 trials
- Sea-blue histiocyte syndrome 0 trials
- Sitosterolemia 0 trials Sub-types →
-
Sterol metabolism disorder 0 trials · 60 incl. sub-types
4 sub-types
- Sterol biosynthesis disorder 0 trials · 45 incl. sub-types Sub-types →
- Cholesterol metabolism disease 3 trials · 13 incl. sub-types Sub-types →
- Inborn disorder of bile acid synthesis 2 trials · 12 incl. sub-types Sub-types →
- Recessive X-linked ichthyosis 2 trials Sub-types →
-
Steroid inherited metabolic disorder 0 trials · 39 incl. sub-types
3 sub-types
- Congenital adrenal hyperplasia 36 trials · 38 incl. sub-types Sub-types →
- Congenital bile acid synthesis defect 1 trial · 2 incl. sub-types Sub-types →
- Apparent mineralocorticoid excess 1 trial
-
Inherited fatty acid metabolism disorder 7 trials · 21 incl. sub-types
3 sub-types
- Disorder of fatty acid oxidation and ketogenesis 1 trial · 16 incl. sub-types Sub-types →
- Carnitine palmitoyl transferase 1A deficiency 1 trial
- Inherited lipoic acid biosynthesis defect 0 trials · 1 incl. sub-types Sub-types →
-
Disorder of phospholipids, sphingolipids and fatty acids biosynthesis 0 trials · 15 incl. sub-types
17 sub-types
- Barth syndrome 5 trials
- Sjogren-Larsson syndrome 3 trials
- Nephrotic syndrome 14 3 trials
- Hereditary sensory and autonomic neuropathy type 1 0 trials · 2 incl. sub-types Sub-types →
- Neutral lipid storage disease 1 trial · 2 incl. sub-types Sub-types →
- 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome 0 trials
- GM3 synthase deficiency 0 trials
- PHARC syndrome 0 trials
- Sengers syndrome 0 trials
- Autosomal recessive complex spastic paraplegia due to kennedy pathway dysfunction 0 trials
- Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome 0 trials
- Fatty acid hydroxylase-associated neurodegeneration 0 trials
- Hereditary spastic paraplegia 39 0 trials Sub-types →
- Megaconial type congenital muscular dystrophy 0 trials
- Progressive encephalopathy with leukodystrophy due to DECR deficiency 0 trials
- Progressive myoclonic epilepsy type 8 0 trials
- Spinocerebellar ataxia type 38 0 trials
-
Hypolipoproteinemia 2 trials · 7 incl. sub-types
3 sub-types
- Hypobetalipoproteinemia 2 trials · 3 incl. sub-types Sub-types →
- Norum disease 2 trials
- Tangier disease 0 trials
-
Glucocorticoid resistance 3 trials
-
2 sub-types
-
CYP7B1-related disorder of oxysterol accumulation 0 trials · 2 incl. sub-types
2 sub-types
- Hereditary spastic paraplegia 5A 2 trials
- Congenital bile acid synthesis defect 3 0 trials
-
Disorder of plasmalogens biosynthesis 0 trials · 2 incl. sub-types
5 sub-types
- Rhizomelic chondrodysplasia punctata 2 trials Sub-types →
- Acyl-CoA binding domain containing protein 5 deficiency 1 trial
- Alkylglycerone-phosphate synthase deficiency 0 trials · 1 incl. sub-types Sub-types →
- Glyceronephosphate O-acyltransferase deficiency 0 trials · 1 incl. sub-types Sub-types →
- Fatty acyl-CoA reductase defects 0 trials Sub-types →
-
Inborn disorder of ketolysis 0 trials · 1 incl. sub-types
2 sub-types
-
Cortisone reductase deficiency 0 trials
2 sub-types
- Cortisone reductase deficiency 1 0 trials
- Cortisone reductase deficiency 2 0 trials
-
8 sub-types
- CHIME syndrome 0 trials
- GM3 synthase deficiency 0 trials
- Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency 0 trials
- Hyperphosphatasia-intellectual disability syndrome 0 trials Sub-types →
- Intellectual disability, autosomal recessive 53 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 1 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 2 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 3 0 trials
-
Lipoid proteinosis 0 trials
-
2 sub-types
- Combined pancreatic lipase-colipase deficiency 0 trials
- Pancreatic colipase deficiency 0 trials
Most studied deeper sub-types
-
Could a diabetes drug before bariatric surgery supercharge weight loss?
Disease control Not yet recruitingThis study will compare three approaches before gastric bypass surgery for severe obesity: taking the medication tirzepatide for 60 days, following a ketogenic diet for 4 weeks, or receiving standard care. The goal is to see which method leads to the most weight loss one year aft…
Sponsor: Mario Musella MD • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Community exercise program aims to boost health in older adults with multiple chronic conditions
Disease control Not yet recruitingThis study tests a community-based exercise program for people aged 50 and older who have at least two chronic conditions, such as heart disease, diabetes, arthritis, or obesity. The program is designed to improve muscle strength, heart and lung fitness, and overall well-being. R…
Sponsor: Associação para o Desenvolvimento do Centro Académico de Investigação e Formação Biomédica do Algarv • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can a new pill tame high cholesterol?
Disease control Not yet recruitingThis early-stage trial is testing an experimental pill called HS-10582 to see if it is safe and how it affects the body, especially LDL cholesterol. The study includes healthy adults and those with mildly elevated LDL cholesterol. Participants will receive either the drug or a pl…
Phase 1 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Pecans may lower cholesterol and curb heart disease risk
Disease control Not yet recruitingThis study tests whether eating a daily serving of pecans for 12 weeks can improve cholesterol levels and other markers of heart-disease risk. Adults aged 25–75 who are overweight or have borderline-high cholesterol will either add pecans to their diet or stick with their usual e…
Sponsor: University of Georgia • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a phone app help older hearts? chile trial aims to find out
Disease control Not yet recruitingThis study tests NeoMayor, a smartphone app that gives personalized advice on exercise, diet, sleep, and mood to improve heart health. Researchers will enroll 240 adults aged 55 to 75 in Chile who are at risk for heart problems. Participants use the app for 4 months, and some als…
Sponsor: University of Chile • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Hormone therapy may shield menopausal hearts and brains — a trial puts it to the test
Disease control Not yet recruitingThis trial explores whether starting transdermal estradiol (a skin gel or patch) soon after menopause can protect the heart and brain in women who have hot flashes and at least one cardiovascular risk factor. One hundred women will be randomly assigned to receive the hormone ther…
Phase 4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Could a tropical oil and green exercise boost fat burning and calm your mind?
Disease control Not yet recruitingThis study looks at whether taking macaúba oil supplements while doing outdoor exercise can improve how the body burns fat and handles mental stress. Researchers will enroll 60 physically active adults aged 35 to 59 who are overweight but not obese. Participants will take either …
Sponsor: Federal University of Minas Gerais • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Sugarcane supplement and exercise may team up to tame cholesterol
Disease control Not yet recruitingThis study tests whether a low-dose sugarcane-derived supplement called policosanol, combined with a structured exercise program, can improve physical fitness and blood lipid levels in adults with elevated cholesterol who do not yet need medication. Over 12 weeks, participants ar…
Sponsor: Mahidol University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a cheap arthritis drug shield kidneys from heart and bone damage?
Disease control Not yet recruitingThis study tests whether a low dose of colchicine, a common anti-inflammatory drug, can slow down blood vessel hardening and bone problems in people with stage 3 chronic kidney disease. About 60 adults will take colchicine or receive usual care for 12 months. The goal is to see i…
Phase 2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New injection aims to tackle high cholesterol in early human trial
Disease control Not yet recruitingThis early-stage trial tests a single injection of MWX205 in 37 adults with high cholesterol or blood fats (dyslipidemia). Researchers will check if the drug is safe, how the body processes it, and how it affects cholesterol levels compared to a placebo. The goal is to find the r…
Phase 1 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can a Salt-Marsh plant extract help control cholesterol?
Disease control Not yet recruitingThis study tests whether a dietary supplement made from halophyte plant extracts (like salicornia) and B vitamins can improve cholesterol levels in people recently diagnosed with dyslipidemia who do not yet need medication. About 250 participants will take the supplement or follo…
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Free produce prescription aims to lower heart risks in kids
Disease control Not yet recruitingThis study will give 150 children and teens with high blood pressure, high cholesterol, or obesity a free debit card to buy fruits and vegetables, plus virtual nutrition classes. The goal is to see if this program helps improve their heart health over 6 to 12 months. Participants…
Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a supplement tame your cholesterol? new study seeks answers
Disease control Not yet recruitingThis study tests a dietary supplement called Cardiol Forte in 50 adults with mildly high cholesterol but low overall heart risk. Participants will take either the supplement or a placebo for 8 weeks, then everyone gets the supplement for another 8 weeks. The goal is to see if it …
Sponsor: U.G.A. Nutraceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Coconut-Based diet could help obese adults improve metabolic health
Disease control Not yet recruitingThis study will test whether a low-calorie diet rich in medium-chain triglycerides (MCTs) from traditional Minangkabau foods can improve metabolic health in 40 obese adults. Participants will follow a diet based on coconut milk dishes for a period, and researchers will measure ch…
Sponsor: Andalas University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
12,000-Patient study tests new cholesterol pill in real life
Disease control Not yet recruitingThis study will follow 12,000 Korean adults with dyslipidemia (high cholesterol) who are prescribed Baroezet Tablet by their doctor. Researchers will measure changes in LDL ("bad") cholesterol and other fats in the blood over 24 weeks, and track any side effects. The goal is to s…
Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Psoriasis drug combo aims to tackle skin and cholesterol in one shot
Disease control Not yet recruitingThis phase 4 trial tests whether adding recaticimab to vunakizumab works better than vunakizumab alone for adults with moderate-to-severe plaque psoriasis and high cholesterol. Forty participants will be randomly assigned to receive either the drug combo or vunakizumab plus a pla…
Phase 4 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Honey paste could melt artery plaque and lower cholesterol
Disease control Not yet recruitingThis study tests whether Yangxin Dawayimixike Honey Paste can reduce carotid artery plaque and improve cholesterol in people with dyslipidemia. Over 400 participants will receive either the honey paste or a placebo for 12 months, with a one-year follow-up. The main goal is to see…
Phase 4 • Sponsor: Xinjiang Uygur Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
AI family doctor app aims to keep heart patients healthy after surgery
Disease control Not yet recruitingThis study tests whether an AI-powered app called 'Smart family doctor' can help people who have had heart surgery (bypass or stent) better control their blood pressure, blood sugar, and cholesterol. About 951 participants from 10-20 hospitals will use the app for personalized he…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can a smartphone app help control heart disease? new study aims to find out
Disease control Not yet recruitingThis study will test a new way to manage heart disease risk using a digital, nurse-led remote monitoring program. About 750 adults with heart conditions will use home devices and answer questionnaires. The goal is to see if this approach helps more patients reach their cholestero…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New program aims to keep seniors with multiple illnesses out of the hospital
Disease control Not yet recruitingThis study tests a comprehensive management service package for older adults (65+) who have two or more chronic conditions like high blood pressure, diabetes, or arthritis. The package includes digital tools, personalized lifestyle advice, and long-term support. Researchers will …
Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 26, 2026 12:59 UTC
-
Face scan could replace blood pressure cuff, study says
Diagnosis Not yet recruitingThis study tests a new, contactless camera technology that measures heart rate, blood pressure, and heart disease risk from a short video of your face. Researchers will compare these readings to standard medical tests in 300 adults aged 30 and older in Jakarta. If accurate, this …
Sponsor: Tarumanagara University • Aim: Diagnosis
Last updated Jun 27, 2026 12:10 UTC
-
A daily pill aims to stop overweight from turning into obesity and diabetes
Prevention Not yet recruitingThis phase 3 trial tests whether orforglipron, a daily oral medication, can help overweight adults reduce their risk of developing obesity-related complications such as type 2 diabetes, high blood pressure, and high cholesterol, as well as progression to class 1 obesity. Particip…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Prevention
Last updated Sep 02, 2026 00:00 UTC
-
Ancient remedy meets modern prebiotic: a new hope for Shift-Worker fatigue?
Symptom relief Not yet recruitingThis trial is testing whether a combination of Bao Yuan Tang, a traditional Chinese medicine extract, and galactooligosaccharides, a type of prebiotic, can improve sleep quality, reduce fatigue, and support better metabolism in female nurses who work night shifts. The study will …
Sponsor: Hepatopancreatobiliary Surgery Institute of Gansu Province • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Fatty meals may trap vitamin e in the blood, study suggests
Knowledge-focused Not yet recruitingThis study investigates how eating three high-fat meals in a row changes vitamin E levels in the blood. Researchers will compare people with normal blood fats to those with high blood fats (hyperlipidemia). The goal is to understand whether fats in the blood can trap vitamin E, p…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 21, 2026 23:00 UTC
-
Vegan vs. carnivore: which diet keeps your arteries cleanest?
Knowledge-focused Not yet recruitingThis study will compare how vegan, omnivorous, and carnivore diets affect the way LDL cholesterol particles clump together in the blood, which can lead to artery plaque. Researchers will measure blood lipids and other health markers in 90 adults aged 25-60 who have followed their…
Sponsor: Liverpool John Moores University • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
Can big data unmask hidden clusters of cardiometabolic disease?
Knowledge-focused Not yet recruitingThis study looks at anonymized health records from about 100,000 people in a Turkish hospital network to see how common cardiometabolic conditions—like obesity, type 2 diabetes, heart disease, fatty liver, and kidney disease—are and how often they occur together. By tracking thes…
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Could vitamin d levels influence cholesterol in obese diabetes patients?
Knowledge-focused Not yet recruitingThis observational study is investigating whether vitamin D levels are linked to cholesterol and other blood fats in obese adults with type 2 diabetes. Researchers will measure vitamin D status and lipid profiles in 150 participants from a diabetes clinic in Cairo. No treatments …
Sponsor: Sinai University • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Mass screening aims to catch silent killers early in pakistan
Knowledge-focused Not yet recruitingThis study screens adults aged 18 and older in suburban and peri-urban areas of Faisalabad, Pakistan, for four major noncommunicable diseases: diabetes, hypertension, obesity, and high cholesterol. Participants who are found to have these conditions are referred to doctors for st…
Sponsor: Getz Pharma • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can a simple WhatsApp message save lives? chile tests new screening nudge
Knowledge-focused Not yet recruitingThis study will send different types of WhatsApp messages to 235,000 people in Chile who are due for cancer or chronic disease screenings. Researchers want to see if the way a message is worded (basic, risk-focused, or peace-of-mind) and whether it mentions one test or both tests…
Sponsor: University of Chile • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New combo pill for cholesterol and blood pressure put to the test
Knowledge-focused Not yet recruitingThis early-stage study will test a new experimental drug called AD-231 in 60 healthy adults. The goal is to see how safe the drug is and how the body processes it, not to treat any disease. Participants will receive a single dose of the drug and have their blood levels measured o…
Phase 1 • Sponsor: Addpharma Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Can a simple clinic referral get couch potatoes moving?
Knowledge-focused Not yet recruitingThis study works with 35 primary care clinics to help them screen patients for physical inactivity and refer them to community-based exercise programs. The goal is to see if this approach can be smoothly integrated into routine care and whether it leads to better health outcomes …
Sponsor: University of South Carolina • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Cholesterol drug showdown: which one do patients actually take?
Knowledge-focused Not yet recruitingThis study will look at medical records from 3,600 people in Japan to see how well they follow their prescribed cholesterol-lowering medication. It compares two drugs, inclisiran and evolocumab, over 12 months. The goal is to understand real-world adherence, not to test new treat…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Cholesterol ratio may predict kidney trouble in diabetes
Knowledge-focused Not yet recruitingThis study will check if a specific cholesterol ratio (non-HDL to HDL) is linked to kidney disease in people with diabetes. Researchers will measure this ratio and kidney function in 84 adults. The goal is to better understand risk factors, not to test a new treatment.
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Meat-Only vs. mediterranean: which diet wins for your heart?
Knowledge-focused Not yet recruitingThis study will compare a carnivore diet (only animal foods) with a Mediterranean diet (fruits, veggies, grains, legumes) in 30 adults aged 30-60 with high LDL cholesterol. Over 3 weeks, researchers will measure how each diet affects cholesterol clumping, blood fats, and blood ve…
Sponsor: Liverpool John Moores University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New computer program aims to cut heart treatment errors
Knowledge-focused Not yet recruitingThis study will test a new computer program designed to help doctors make better decisions for patients with high cholesterol and heart disease. Researchers will review the medical records of 500 adults and compare the program's recommendations to what doctors actually prescribed…
Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Statins and running: new study to reveal hidden effects on endurance athletes
Knowledge-focused Not yet recruitingThis study looks at how the cholesterol-lowering drug rosuvastatin affects fitness and muscle symptoms in people who run long distances at least three times a week. Researchers will compare runners taking rosuvastatin to those not taking it over three months, measuring changes in…
Sponsor: Taipei Medical University WanFang Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Massive diabetes registry aims to unlock secrets of metabolic disease
Knowledge-focused Not yet recruitingThis 10-year observational study will follow 10,000 adults with diabetes, metabolic disorders, and related conditions like high blood pressure and fatty liver disease. Researchers will collect routine medical data to identify markers of disease severity and activity. The goal is …
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC